Your browser doesn't support javascript.
loading
TGFß promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Laurent, Paôline; Allard, Benoit; Manicki, Pauline; Jolivel, Valérie; Levionnois, Emeline; Jeljeli, Mohamed; Henrot, Pauline; Izotte, Julien; Leleu, Damien; Groppi, Alexis; Seneschal, Julien; Constans, Joel; Chizzolini, Carlo; Richez, Christophe; Duffau, Pierre; Lazaro, Estibaliz; Forcade, Edouard; Schaeverbeke, Thierry; Pradeu, Thomas; Batteux, Frédéric; Blanco, Patrick; Contin-Bordes, Cécile; Truchetet, Marie-Elise.
Afiliação
  • Laurent P; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Allard B; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Manicki P; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
  • Jolivel V; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Levionnois E; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Jeljeli M; Immunology Department, CHU Cochin Hospital, University of Paris Descartes Faculty of Medicine Paris Center, Paris, France.
  • Henrot P; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
  • Izotte J; Animal Facility A2, University of Bordeaux, Talence, France.
  • Leleu D; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Groppi A; Centre de Bioinformatique de Bordeaux (CBiB), University of Bordeaux, Talence, France.
  • Seneschal J; IBGC, CNRS, UMR 5095, University of Bordeaux, Talence, France.
  • Constans J; Dermatology Department, CHU de Bordeaux, Bordeaux, France.
  • Chizzolini C; INSERM U1035, University of Bordeaux, Talence, France.
  • Richez C; Vascular Medicine Department, CHU de Bordeaux, Bordeaux, France.
  • Duffau P; Immunology and Allergy, University of Geneva, Geneva, Switzerland.
  • Lazaro E; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Forcade E; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
  • Schaeverbeke T; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Pradeu T; Internal Medicine, CHU de Bordeaux, Bordeaux, France.
  • Batteux F; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Blanco P; Internal Medicine, CHU de Bordeaux, Bordeaux, France.
  • Contin-Bordes C; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
  • Truchetet ME; Hematology, CHU de Bordeaux, Bordeaux, France.
Ann Rheum Dis ; 80(12): 1594-1603, 2021 12.
Article em En | MEDLINE | ID: mdl-34285051
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele / Linfócitos / Fator de Crescimento Transformador beta / Fibroblastos Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele / Linfócitos / Fator de Crescimento Transformador beta / Fibroblastos Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França